Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction

Catheterization and Cardiovascular Interventions

Volumn 53, Issue 1, 2001, Pages 6-11

  Michael Gibson, C ^a,b,c   Kirtane, Ajay J ^a,b   Murphy, Sabina A ^a   Marble, Susan J ^a   De Lemos, James A ^a,b   Antman, Elliot M ^a,b   Braunwald, Eugene ^a  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute myocardial infarction; Angiography; Contrast agent; Coronary blood flow; Thrombolysis

Indexed keywords

ABCIXIMAB; FIBRINOLYTIC AGENT; IONIC CONTRAST MEDIUM; NONIONIC CONTRAST MEDIUM; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DISEASE DURATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; ST SEGMENT; THORAX PAIN; TREATMENT OUTCOME;

AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE VOLUME; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0035042459     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.1121     Document Type: Article

References (29)

1. Influence of a nonionic, iso-osmolar contrast medium (Iodixanol) versus an ionic, low-osmolar contrast medium (Ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty
2. Randomized trial of contrast media utilization in high-risk PTCA: The COURT trial
3. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty
4. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty
5. Effects of nonionic versus ionic contrast media on complications of percutaneous transluminal coronary angioplasty
6. Effects of an ionic versus a nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty
7. Risk of thrombosis during coronary angioplasty with low osmolality contrast media
8. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina
9. A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb)
10. Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial: - The TIMI 14 Investigators
11. Combination reperfusion therapy with abciximab and reduced dose reteplase: Results from TIMI 14
12. The thrombolysis in myocardial infarction (TIMI) trial
13. The TIMI frame count: A quantitative method of assessing coronary artery flow
14. The relationship between the timi frame count and clinical outcomes after thrombolytic administration
15. The TIMI frame count in saphenous vein grafts
16. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected thrombolysis in myocardial infarction (TIMI) frame count and stenosis severity
17. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials
18. Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: Observations from the TIMI 14 trial
19. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction
20. Blood clot formation in angiographic syringes containing nonionic contrast media
21. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology
22. Effect of heparin in nonionic contrast media on blood coagulation and its dose response curve
23. Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast media
24. The potential risk of thrombosis during coronary angiography using nonionic contrast media
25. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces
26. Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro
27. Influence of contrast media on thrombus formation during coronary angioplasty
28. The potential thrombogenic action of a nonionic radiographic contrast medium used during coronary angiography is offset by heparin during coronary angioplasty